Markets
Alerts
F&O
MF
Reports
Screeners
Subscribe
Superstars
Portfolio
Watchlist
Insider Trades
Results
Data Downloader
Events Calendar
What's New
Explore
FAQs
Widgets
More
Search stocks
IND
USA
IND
IND
×
Close
IND
USA
Stocks
Futures & Options
Mutual Funds
News
Fundamentals
Reports
Corporate Actions
Alerts
Shareholding
Overview
Buy Sell Zone
F&O
Financials
News
All
News
Earnings Calls
Corporate Announcements
Research Reports
Reports
Technicals
Technicals
Share Price History
Delivery
Shareholding
Shareholding
Monthly MF Holdings
Bulk Block Deals
Insider Trading & SAST
Deals
Bulk Block Deals
Insider Trading & SAST
Corporate Actions
All
Dividend
Bonus
Split
Rights
Board Meetings
Alerts
About
Divi's Laboratories Ltd.
NSE: DIVISLAB
|
BSE: 532488
|
ISIN: INE361B01024
|
Industry: Pharmaceuticals
|
Expensive Star
6870.5000
-113.00
(
-1.62
%)
NSE
Jul 10, 2025
14:50 PM
New 52W High in past week
Volume:
124.6K
Share on Facebook
Tweet
Share on LinkedIn
Share via Whatsapp
Divi's Laboratories Ltd.
13 Aug 2022
6870.50
-1.62%
Divi's Labs (HOLD): No respite in sight for margins
Hold:
Divi's Laboratories Ltd.
by
BOB Capital Markets Ltd.
Target: 4250
BOB Capital Markets Ltd.
Q1 revenue broadly in line with consensus at Rs 22.5bn (+15% YoY/-10% QoQ), but EBITDA 10% below
Divi's Laboratories Ltd. is trading above all available SMAs
More from Divi's Laboratories Ltd.
Recommended
Market trades lower, SBI plans a Rs 25,000 crore share sale via a QIP
Trendlyne Marketwatch |
10 Jul 2025, 02:49PM
Five winners from analysts: Stocks set to start FY26 with a bang | Screener: Stocks analysts are most …
The Baseline |
10 Jul 2025, 12:14PM
Custom synthesis business drives growth for Divi’s Laboratories
|
10 Mar 2022, 06:14AM